PSMA radioligand therapy in prostate cancer: overview, latest advances and remaining challenges.

A Patrikidou, Y Loriot, J-C Eymard, L Albiges, C Massard, E Ileana, M Di Palma, B Escudier, K Fizazi, Who dies from prostate cancer Prostate Cancer and Prostatic Diseases. ,vol. 17, pp. 348- 352 ,(2014) , 10.1038/PCAN.2014.35

Joseph R. Osborne, Naveed H. Akhtar, Shankar Vallabhajosula, Alok Anand, Kofi Deh, Scott T. Tagawa, Prostate-specific membrane antigen-based imaging Urologic Oncology: Seminars and Original Investigations. ,vol. 31, pp. 144- 154 ,(2013) , 10.1016/J.UROLONC.2012.04.016

David G. Bostwick, Anna Pacelli, Michael Blute, Patrick Roche, Gerald P. Murphy, Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma Cancer. ,vol. 82, pp. 2256- 2261 ,(1998) , 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S

Scott T. Tagawa, Matthew I. Milowsky, Michael Morris, Shankar Vallabhajosula, Paul Christos, Naveed H. Akhtar, Joseph Osborne, Stanley J. Goldsmith, Steve Larson, Neeta Pandit Taskar, Howard I. Scher, Neil H. Bander, David M. Nanus, Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer Clinical Cancer Research. ,vol. 19, pp. 5182- 5191 ,(2013) , 10.1158/1078-0432.CCR-13-0231

Carlos Cordon-Cardo, Warren D. W. Heston, Inmaculada Pellicer, William R. Fair, David A. Silver, Prostate-specific membrane antigen expression in normal and malignant human tissues. Clinical Cancer Research. ,vol. 3, pp. 81- 85 ,(1997)

Christian M. Zechmann, Ali Afshar-Oromieh, Tom Armor, James B. Stubbs, Walter Mier, Boris Hadaschik, John Joyal, Klaus Kopka, Jürgen Debus, John W. Babich, Uwe Haberkorn, Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 41, pp. 1280- 1292 ,(2014) , 10.1007/S00259-014-2713-Y

Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil, Uwe Haberkorn, Michael Schäfers, Markus Essler, Richard P. Baum, Harshad R. Kulkarni, Matthias Schmidt, Alexander Drzezga, Peter Bartenstein, Andreas Pfestroff, Markus Luster, Ulf Lützen, Marlies Marx, Vikas Prasad, Winfried Brenner, Alexander Heinzel, Felix M. Mottaghy, Juri Ruf, Philipp Tobias Meyer, Martin Heuschkel, Maria Eveslage, Martin Bögemann, Wolfgang Peter Fendler, Bernd Joachim Krause, German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients. The Journal of Nuclear Medicine. ,vol. 58, pp. 85- 90 ,(2017) , 10.2967/JNUMED.116.183194

John Babich, Clemens Kratochwil, Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, Thomas Armor, Walter Mier, Fabian Spohn, Nils Debus, Tim Holland-Letz, Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095 European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 44, pp. 950- 959 ,(2017) , 10.1007/S00259-017-3665-9

Hojjat Ahmadzadehfar, Simone Wegen, Anna Yordanova, Rolf Fimmers, Stefan Kürpig, Elisabeth Eppard, Xiao Wei, Carl Schlenkhoff, Stefan Hauser, Markus Essler, Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 44, pp. 1448- 1454 ,(2017) , 10.1007/S00259-017-3716-2

Wolfgang P. Fendler, Kambiz Rahbar, Ken Herrmann, Clemens Kratochwil, Matthias Eiber, 177Lu-PSMA Radioligand Therapy for Prostate Cancer. The Journal of Nuclear Medicine. ,vol. 58, pp. 1196- 1200 ,(2017) , 10.2967/JNUMED.117.191023